POSTCARE-O: Survivorship Care for Women Living With Ovarian Cancer
This study will enroll 120 women living with ovarian cancer following completion of initial treatment. Our objective is to test an intervention designed to provide support during the survivorship transition for this population, who live with a high degree of morbidity related to the illness and its treatment as well as a high risk of recurrence. Study participants will be randomly assigned to receive survivorship care using the POSTCare-O process or usual care. The primary outcome is quality of life at 12 weeks after intervention.
• Stage 2-4 ovarian cancer
• Treated with some combination of surgery, chemotherapy, biologics, maintenance therapy
• Within 6 months of completion of initial treatment (continued maintenance therapy okay)
• Able to provide consent in English or Spanish